Dillon & Associates Inc Bristol Myers Squibb CO Transaction History

Dillon & Associates Inc

$688 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $4,341 - $4,854	-75 Reduced 1.98%	3,715 $215,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $955 - $1,061	-15 Reduced 0.39%	3,790 $243,000
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $9,856 - $11,179	-150 Reduced 3.79%	3,805 $263,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $9,856 - $11,179	150 Added 3.94%	3,955 $274,000
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $10,272 - $12,163	-150 Reduced 3.79%	3,805 $274,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $24,830 - $28,946	-463 Reduced 10.48%	3,955 $245,000
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $532 - $623	-9 Reduced 0.2%	4,418 $261,000
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $73,053 - $79,555	-1,180 Reduced 21.05%	4,427 $297,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $3,026 - $3,403	-51 Reduced 0.9%	5,607 $353,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $2,944 - $3,336	51 Added 0.91%	5,658 $351,000
Q3 2020 Nov 06, 2020	SELL	$57.43 - $63.64 $4,422 - $4,900	-77 Reduced 1.35%	5,607 $336,000
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $279,709 - $364,855	5,684 New	5,684 $364,000
Q1 2019 May 07, 2019	SELL	$45.12 - $53.8 $184,540 - $220,042	-4,090 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $56,074 - $72,714	-1,150 Reduced 21.95%	4,090 $213,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $28,422 - $32,058	-515 Reduced 8.95%	5,240 $325,000
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $50,530 - $62,980	1,000 Added 21.03%	5,755 $317,000
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $599 - $689	-10 Reduced 0.21%	4,755 $300,000
Q4 2017 Feb 08, 2018	BUY	$59.94 - $65.35 $32,367 - $35,289	540 Added 12.78%	4,765 $291,000
Q2 2017 Aug 09, 2017	BUY	N/A	4,225	4,225 $237,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Account